Benito Kristen, Pittig Andre, Abramowitz Jonathan, Arch Joanna J, Chavira Denise, de Kleine Rianne, De Nadai Alessandro S, Hermans Dirk, Hofmann Stefan G, Hoyer Jürgen, Huppert Jonathan D, Kircanski Katharina, McEvoy Peter M, Meyer Heidi, Monfils Marie-H, Papini Santiago, Rief Winfried, Rosenfield David, Storch Eric A, Telch Michael J, Otto Michael W, Smits Jasper A J
Brown University Warren Alpert Medical School, Psychiatry and Human Behavior, Providence, RI, US.
Emma Pendleton Bradley Hospital, Pediatric Anxiety Research Center, East Providence, US.
Clin Psychol Sci. 2025 Jul;13(4):687-719. doi: 10.1177/21677026241240727. Epub 2024 May 25.
Anxiety and related disorders are a significant public health burden with rising prevalence in the wake of the COVID-19 pandemic. As demand for effective anxiety treatment increases, so too does the need for strategies to bolster treatment outcomes. Research on the mechanisms of exposure therapy, the frontline behavioral treatment, will be critically important for optimizing clinical outcomes. We outline an initial agenda for future research on the mechanisms of change of exposure therapy, developed in collaboration with a large international team of researchers through the Exposure Therapy Consortium (ETC). Key questions and recommendations for future research focus on five priority areas: conceptualization, measurement, study design/analysis, and individual/contextual differences. Rising to the challenge of addressing these questions will require coordinated action and availability of centralized tools that can be used across trials, settings, and research groups.
焦虑症及相关障碍是一项重大的公共卫生负担,在新冠疫情之后患病率不断上升。随着对有效焦虑症治疗的需求增加,提高治疗效果的策略需求也随之增加。作为一线行为治疗方法的暴露疗法的机制研究,对于优化临床结果至关重要。我们概述了暴露疗法改变机制的未来研究初步议程,该议程是通过暴露疗法联盟(ETC)与一个大型国际研究团队合作制定的。未来研究的关键问题和建议集中在五个优先领域:概念化、测量、研究设计/分析以及个体/背景差异。应对这些问题的挑战需要协调行动,并提供可在不同试验、环境和研究小组中使用的集中工具。